Share class: The Biotech Growth Trust PLC

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A119,346,39919,226,940 ( 99.38 %) 0 99.38 %

Major shareholders: The Biotech Growth Trust PLC

NameStocks%Valuation
Rathbones Investment Management Ltd.
10.62 %
2,061,139 10.62 % 36 M p
Brewin Dolphin Ltd.
9.167 %
1,779,234 9.167 % 31 M p
Border to Coast Pensions Partnership Ltd.
6.62 %
1,284,902 6.62 % 23 M p
West Yorkshire Pension Fund
5.59 %
1,084,889 5.59 % 19 M p
Hargreaves Lansdown Fund Managers Ltd.
5.209 %
1,011,000 5.209 % 18 M p
TrinityBridge Ltd.
1.834 %
356,000 1.834 % 6 M p
BlackRock Investment Management (UK) Ltd.
1.402 %
272,035 1.402 % 5 M p
UBS Asset Management (Americas) LLC
1.221 %
237,000 1.221 % 4 M p
Unicorn Asset Management Ltd.
1.03 %
200,000 1.03 % 4 M p
Forsyth Barr Custodians Ltd.
0.9207 %
178,708 0.9207 % 3 M p
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional54.6%
Others1.73%
Individuals0.13%
Unknown43.54%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom
50.94%
United States
2.31%
New Zealand
1.04%
Switzerland
0.94%
France
0.42%
South Africa
0.26%
Individuals
0.13%
Hong Kong
0.13%
Denmark
0.1%
Germany
0.07%
Singapore
0.07%
China
0.05%

Based on 1000 largest holdings

Logo The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a United Kingdom-based externally managed investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. The Company invests more than 10%, in aggregate, of the value of its gross assets in other closed-end investment companies (including investment trusts) listed on the London Stock Exchange. The Company invests more than 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes the Netherlands, the United States of America, Canada, and China. The Company’s alternative investment fund manager is Frostrow Capital LLP.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!